⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3860250 | 1.00 | — | — | |
| SCHEMBL8768172 | 1.00 | FFAR3 (0.35) | — | |
| SCHEMBL43232 | 1.00 | — | — | |
| SCHEMBL29396747 | 1.00 | FFAR3 (0.35) | — | |
| SCHEMBL11607991 | 0.97 | FOLH1 (0.33) | — | |
| SCHEMBL28015494 | 0.97 | FOLH1 (0.33) | — | |
| L-Lactic Acid SCHEMBL31285806 | 0.90 | TP53 (0.52) | — | |
| SCHEMBL108300 | 0.84 | TSHR (0.41) | — | |
| 2-Oxoisohexanoate SCHEMBL25436317 | 0.84 | CA2 (0.38) | — | |
| SCHEMBL3755021 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 151 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119899102-A | Synthesis method of alpha-ketoisoleucine calcium intermediate and application of alpha-ketoisoleucine calcium intermediate in preparation of alpha-ketoisoleucine calcium | 河北天成药业股份有限公司 | 2025-04-29 | — | — | CN | claimed |
| WO-2024150158-A1 | IL-7 POLYPEPTIDES, IMMUNOCYTOKINES COMPRISING SAME, AND USES THEREOF | BRIGHT PEAK THERAPEUTICS AG (CH) | 2024-07-18 | — | — | WO | claimed |
| EP-4366780-A1 | SYNTHETIC IL-7 AND IL-7 IMMUNOCYTOKINES | Bright Peak Therapeutics AG (CH) | 2024-05-15 | — | — | EP | claimed |
| US-20230405091-A1 | METHODS OF MODULATING GASTROINTESTINAL METABOLITES | DSM IP ASSETS B.V. (NL) | 2023-12-21 | — | — | US | claimed |
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| EP-4228424-A1 | METHODS OF MODULATING GASTROINTESTINAL METABOLITES | DSM IP Assets B.V. (NL) | 2023-08-23 | — | — | EP | claimed |
| CN-116390651-A | Methods of modulating gastrointestinal metabolites | 帝斯曼知识产权资产管理有限公司 | 2023-07-04 | — | — | CN | claimed |
| US-20230200412-A1 | METHODS OF MODULATING GASTROINTESTINAL MICROBIAL METABOLIC PATHWAYS AND METABOLITES | DSM IP ASSETS B.V. (NL) | 2023-06-29 | — | — | US | claimed |
| EP-4200323-A2 | MODIFIED IL-18 POLYPEPTIDES AND USES THEREOF | Bright Peak Therapeutics AG (CH) | 2023-06-28 | — | — | EP | claimed |
| EP-4118090-A1 | METHODS OF MODULATING GASTROINTESTINAL MICROBIAL METABOLIC PATHWAYS AND METABOLITES | DSM IP Assets B.V. (NL) | 2023-01-18 | — | — | EP | claimed |
| WO-2021183896-A1 | METHODS OF MODULATING GASTROINTESTINAL MICROBIAL METABOLIC PATHWAYS AND METABOLITES | DSM IP ASSETS, B.V. (NL) | 2021-09-16 | — | — | WO | claimed |
| US-20180003721-A1 | Metabolite Biomarkers Predictive Of Renal Disease In Diabetic Patients | JOSLIN DIABETES CENTER (US) | 2018-01-04 | — | — | US | claimed |
| WO-2016115496-A1 | METABOLITE BIOMARKERS PREDICTIVE OF RENAL DISEASE IN DIABETIC PATIENTS | JOSLIN DIABETES CENTER (US) | 2016-07-21 | — | — | WO | claimed |
| US-8494779-B2 | Method for screening essential metabolites in growth of microorganisms | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2013-07-23 | — | — | US | claimed |
| US-20100143911-A1 | METHOD FOR SCREENING ESSENTIAL METABOLITES IN GROWTH OF MICROORGANISMS | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2010-06-10 | — | — | US | claimed |
| EP-2097743-A1 | METHOD FOR SCREENING ESSENTIAL METABOLITES IN GROWTH OF MICROORGANISMS | Korea Advanced Institute of Science and Technology (KR) | 2009-09-09 | — | — | EP | claimed |
| WO-2008078911-A1 | METHOD FOR SCREENING ESSENTIAL METABOLITES IN GROWTH OF MICROORGANISMS | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2008-07-03 | — | — | WO | claimed |
| EP-0921186-B1 | Use of ethyl 3-methyl-2-oxopentanoate as a perfuming ingredient | FIRMENICH & CIE (CH) | 2004-11-03 | — | — | EP | claimed |
| EP-0921186-A2 | Use of ethyl 3-methyl-2-oxopentanoate as a perfuming ingredient | FIRMENICH SA (CH) | 1999-06-09 | — | — | EP | claimed |
| EP-0406811-A2 | Novel clathrate compounds and a drug comprising them | AJINOMOTO CO., INC. (JP) | 1991-01-09 | — | — | EP | claimed |